Coherus Content With Dual Pipeline Strategy

US Firm Reveals Full-Year Udenyca Biosimilar Sales

 
• By Dean Rudge
  
Road_Mountain
Coherus is finally in year-end profit after launching its first product • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business